Clinical Trial Update: Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase for Infants and Children [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating subcutaneous rehydration with recombinant human hyaluronidase in infants and children with dehydration completed, and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dehydration

Drugs mentioned

• Recombinant human hyaluronidase (recombinant human hyaluronidase (rHuPH20))

Snippet

Sponsor: Baxter Healthcare Corporation | Conditions: Dehydration | Phase 4 | Status: COMPLETED | Results posted: 2011-11-23